BioNTech recruits rivals to boost Covid-19 vaccine production

With 13 companies partnering, the goal is to reach production of 2 billion doses as early as 2021.

RIO DE JANEIRO, BRAZIL - The maker of the West’s first Covid-19 vaccine is building a new manufacturing alliance that could throw Europe and the rest of the world a lifeline amid a painful shortage of shots and a rebound in infections.

The German company that joined with Pfizer to manufacture and distribute its vaccine, has marshaled an alliance of 13 companies, including Novartis, Merck KGaA and Sanofi, in an effort to meet—and perhaps exceed—an ambitious target of making 2 billion doses of vaccine this year.

The European Union has been struggling with a shortage of vaccines . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?